Rhumbline Advisers Decreases Position in The Clorox Company $CLX

Rhumbline Advisers trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 4.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 260,405 shares of the company’s stock after selling 13,057 shares during the period. Rhumbline Advisers’ holdings in Clorox were worth $31,267,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. American National Bank & Trust lifted its stake in shares of Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after acquiring an additional 89 shares during the last quarter. NewSquare Capital LLC grew its position in Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after acquiring an additional 193 shares during the last quarter. Hantz Financial Services Inc. purchased a new position in Clorox in the 2nd quarter worth approximately $31,000. Ransom Advisory Ltd bought a new stake in Clorox in the first quarter valued at approximately $35,000. Finally, MTM Investment Management LLC purchased a new stake in shares of Clorox during the second quarter valued at approximately $37,000. 78.53% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. TD Cowen decreased their target price on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research note on Wednesday, October 1st. Morgan Stanley cut their price target on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Bank of America decreased their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Jefferies Financial Group reiterated a “buy” rating and set a $152.00 target price on shares of Clorox in a report on Tuesday, November 4th. Finally, Wells Fargo & Company reduced their price target on Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. One investment analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average target price of $125.69.

Clorox Price Performance

Shares of NYSE CLX opened at $107.75 on Thursday. The Clorox Company has a 1 year low of $98.20 and a 1 year high of $171.37. The stock has a market capitalization of $13.14 billion, a P/E ratio of 16.53, a P/E/G ratio of 0.92 and a beta of 0.52. The company’s 50-day moving average is $114.23 and its 200 day moving average is $121.67. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the previous year, the firm posted $1.86 EPS. The business’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.6%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio is presently 77.86%.

Insiders Place Their Bets

In other news, Director Pierre R. Breber acquired 4,000 shares of the firm’s stock in a transaction on Friday, November 21st. The stock was acquired at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director owned 13,000 shares in the company, valued at $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.63% of the stock is currently owned by corporate insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.